Magnetic resonance imaging and late-life depression: potential biomarkers in the era of personalized medicine.
Kumar
Anand
A
Ajilore
Olusola
O
D000367:Age Factors; D016880:Anisotropy; D054316:Biomarkers, Pharmacological; D001834:Body Water / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000648:ultrastructure; D015283:Citalopram / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods / Q000706:statistics & numerical data; D015195:Drug Design; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods* / Q000706:statistics & numerical data; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D054316:Biomarkers, Pharmacological; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors